台康生技(6589)股票可以買嗎?K線圖AI分析回答目標合理價

K線圖與股價本日交易資訊

資料日期: ,每天14:00後更新。

本日股價資訊
66.1 66.7 65.5 65.8
查看每日股價資訊表格
每日股價資訊
日期 開盤價 最高價 最低價 收盤價 成交量
2025/05/09 62 62 61.3 61.9 132
2025/05/12 62.2 63 62 62.4 282
2025/05/13 63.5 63.8 61.2 61.7 822
2025/05/14 62.3 65.4 62.3 64.5 605
2025/05/15 64.2 64.4 63.3 63.3 302
2025/05/16 64 64 62.8 63 156
2025/05/19 63 68.4 63 65.9 1,133
2025/05/20 66.1 66.3 64.2 64.5 634
2025/05/21 64.7 65 64.2 64.4 181
2025/05/22 65 66 63.6 63.7 300
2025/05/23 64 64.3 63.3 63.6 178
2025/05/26 63.6 63.9 63.1 63.1 167
2025/05/27 63.5 64.3 62.7 62.9 215
2025/05/28 63 64.1 63 63.2 169
2025/05/29 63.4 64.1 62.8 62.9 242
2025/06/02 62.8 63 61.5 61.5 250
2025/06/03 61.8 62.4 61.7 61.9 174
2025/06/04 62.5 63.8 61.8 63.6 287
2025/06/05 63.9 63.9 63.2 63.4 165
2025/06/06 64.2 64.2 63 63.7 174
2025/06/09 63.8 63.8 62.8 63.1 132
2025/06/10 62.7 62.9 62 62 297
2025/06/11 62 62.5 61.6 61.8 231
2025/06/12 62.4 63.2 62.1 62.8 222
2025/06/13 62.8 64.3 61.9 62.1 547
2025/06/16 62 62 60.8 61.1 291
2025/06/17 61.3 61.7 60.8 60.9 216
2025/06/18 61.8 61.8 60.6 60.6 196
2025/06/19 60.6 60.8 59.4 59.6 378
2025/06/20 60.1 65.5 60.1 65.5 2,238
2025/06/23 66 66.7 61.7 62.6 2,868
2025/06/24 62.8 64.1 62.8 64.1 791
2025/06/25 64.9 64.9 63.6 64 445
2025/06/26 64.5 64.6 63.6 63.6 336
2025/06/27 63.3 63.7 62.1 62.8 548
2025/06/30 62.9 63 61.4 61.4 371
2025/07/01 62.3 62.8 61.6 62.1 295
2025/07/02 62.1 63.8 62.1 63.8 332
2025/07/03 63.8 64 63.5 64 172
2025/07/04 63.7 64.5 62.4 62.4 450
2025/07/07 62.2 62.2 61.3 61.5 272
2025/07/08 61 62.1 60.2 61.9 399
2025/07/09 61.7 61.8 61.1 61.4 204
2025/07/10 61.4 63.1 61 61.9 252
2025/07/11 62.2 62.5 61.8 62.5 169
2025/07/14 62.2 62.4 61.5 61.6 139
2025/07/15 62 62.8 61.6 62.8 196
2025/07/16 63 64.2 62.5 63.6 395
2025/07/17 63.6 66.5 63.6 66.1 834
2025/07/18 66.2 67.3 65.4 66.4 701
2025/07/21 67.2 67.8 65.9 65.9 506
2025/07/22 65.6 66.4 64 64 806
2025/07/23 65 67.8 65 67.6 813
2025/07/24 68.2 68.2 65.4 67.6 845
2025/07/25 67.5 68.2 66.8 67.5 428
2025/07/28 67.5 67.7 65.5 65.8 672
2025/07/29 65.8 65.9 64.5 65 257
2025/07/30 65.1 65.2 64.3 64.5 258
2025/07/31 65 65 64 64 249
2025/08/01 63.2 63.5 62.1 63.1 241
2025/08/04 62.6 63.5 61.6 63.1 235
2025/08/05 62.7 64.9 62.7 64.2 344
2025/08/06 64.2 64.8 62.5 62.5 420
2025/08/07 62.4 62.6 61.2 61.8 493
2025/08/08 61.5 62.3 61.5 62 299
2025/08/11 61.7 61.8 60.5 60.9 571
2025/08/12 61 61.7 61 61.4 195
2025/08/13 61.9 62.4 61.4 62.2 327
2025/08/14 62.2 63.4 62.2 62.9 276
2025/08/15 62.5 62.8 61.6 61.7 356
2025/08/18 61.4 61.4 59.5 60.7 509
2025/08/19 60.7 61 60.1 60.5 365
2025/08/20 60.2 60.9 59.8 60.3 415
2025/08/21 61 61.7 60.9 61.2 199
2025/08/22 61.1 62.4 61.1 61.6 448
2025/08/25 62.8 62.8 61.4 61.5 445
2025/08/26 61.5 62.5 60.3 62.5 619
2025/08/27 61.8 63.7 61.4 61.5 597
2025/08/28 62 63 61.4 61.4 394
2025/08/29 61.9 61.9 60.6 60.9 858
2025/09/01 60.9 61.5 60.1 60.2 366
2025/09/02 60.2 61.9 60.2 60.3 548
2025/09/03 61 61.5 60.3 61.4 326
2025/09/04 61.5 62.1 61.4 61.6 312
2025/09/05 62.7 64 62.4 63.5 1,059
2025/09/08 65.4 68.8 65 65.1 3,515
2025/09/09 65.2 65.2 63.1 63.5 1,380
2025/09/10 63.2 63.2 61.8 62.4 908
2025/09/11 62.1 63 61.2 61.4 722
2025/09/12 61.5 62.3 61 61 490
2025/09/15 61 61.4 60.6 60.7 563
2025/09/16 61 61.3 60.4 60.7 344
2025/09/17 60.7 61.4 60.4 60.5 495
2025/09/18 60.7 61.2 60.6 60.8 406
2025/09/19 61 61.5 60 60 842
2025/09/22 60.3 60.7 60.2 60.5 296
2025/09/23 60.4 60.8 60.3 60.6 296
2025/09/24 61.4 61.9 60.5 60.7 532
2025/09/25 62.8 63.8 62 62.9 1,209
2025/09/26 63.7 68.3 62.8 66.7 4,797
2025/09/30 67.4 70.5 65.5 70.3 4,838
2025/10/01 70.6 76 69.5 72.8 4,870
2025/10/02 73 75.4 72.6 74 4,978
2025/10/03 74.2 76 71.4 72.3 5,488
2025/10/07 73.5 75 72.2 73 3,513
2025/10/08 72.6 72.9 71.2 72 1,549
2025/10/09 72.1 73.3 71 71.5 2,304
2025/10/13 70.2 72.4 68.5 72.4 1,996
2025/10/14 72.3 76 72.2 74.8 3,432
2025/10/15 74.3 76 69.7 69.7 3,722
2025/10/16 70.1 70.9 68.7 70.2 1,394
2025/10/17 70.2 71.6 69.8 70.3 754
2025/10/20 71 71.2 68.2 68.5 1,258
2025/10/21 69 72.2 69 69.7 913
2025/10/22 70.8 70.8 69.1 70.2 945
2025/10/23 70 70.4 69 69.1 1,145
2025/10/27 69.6 69.6 67 67.5 984
2025/10/28 68.5 69.2 67 67.1 652
2025/10/29 67.1 67.5 65.9 66.1 625
2025/10/30 66.1 66.7 65.5 65.8 576

AI的K線圖分析和操作建議

以下內容由AI生成:

點擊查看。AI建議自動產生於:,輸入:市場模型。 台康生技 (6589) 股價走勢分析與操作建議 未來趨勢預…

台康生技 (6589) 股價走勢分析與操作建議

未來趨勢預測

根據所提供的台康生技 (6589) 近 90 天 K 線圖,觀察其近期的股價表現,顯示出股價有逐漸走弱的跡象。儘管在 9 月下旬出現了一波強勁的上漲,但隨後股價未能持續攻堅,進入了整理甚至下滑的階段。MA5 (短期均線) 已多次下彎,且有穿越 MA20 (長期均線) 的跡象,這通常預示著短期趨勢可能轉弱。成交量柱狀圖在近期上漲期間有放大,但隨後股價拉回時,成交量並未明顯萎縮,這可能表明市場在該價位有持續的賣壓。綜合以上觀察,預計未來數天或數週,台康生技股價可能呈現盤整或小幅下跌的趨勢

技術面分析

從圖表中可見,台康生技股價在 2025 年 9 月下旬經歷了一次顯著的上漲,最高觸及約 77 元的價位。此波上漲伴隨著成交量的放大,顯示有買盤積極介入。然而,隨後股價快速回落,並在 10 月初進入了下跌通道。MA5 在 10 月初從價格上方快速下彎,並已接近 MA20。MA20 則呈現緩慢上升的趨勢,但其斜率已趨於平緩,且與股價的距離逐漸拉近。這表明多頭力道正在減弱,空頭壓力可能正在增加。

從 K 線組合來看,近期出現了較多的綠色 K 線(代表下跌),且上影線較長,這暗示著股價在嘗試反彈時遭遇了賣壓。成交量柱狀圖顯示,在 9 月下旬的拉抬過程中成交量可觀,但隨後幾天的下跌和整理,雖然成交量相較於高點有所下降,但並未出現明顯的縮量,這顯示市場上仍存在觀望或謹慎的賣壓。

觀察圖表的左側,股價在 70 元至 75 元的區間曾有較長的整理時間,此區間可視為一個前期的密集交易區。而近期股價已跌破此區間,並在 60 元至 65 元的區間進行測試。如果股價無法有效站穩 60 元的整數關卡,則有可能繼續向下尋找支撐。

未來目標價格區間

基於目前的技術指標和近期走勢,預計台康生技在未來數週的股價可能在 58 元至 64 元的區間內波動。若市場情緒持續悲觀或出現利空消息,股價有可能測試甚至跌破 58 元的支撐。反之,若有重大利好消息出現,且能有效帶動買盤,則有機會回到 64 元以上的價位,但短期內要突破 65 元以上並站穩的難度較高。

操作建議 (針對散戶投資人)

對於「台康生技 (6589) 可以買嗎?」的疑問,考量到目前的技術面顯示股價有轉弱跡象,且 MA5 正朝 MA20 下彎,成交量也未呈現明顯的止跌訊號,因此,建議散戶投資人目前暫時觀望,不宜貿然進場追價或承接

若手中有持股的投資人:

  • 停損為先: 建議設定一個明確的停損點。若股價跌破 60 元,且短期內未見反彈,可考慮減碼或出場,以避免進一步的損失。
  • 耐心等待: 如果對該公司基本面有信心,可以將其視為一個潛在的長期投資標的,但仍需耐心等待股價出現更明確的止跌訊號和反彈機會。

若想逢低布局的投資人:

  • 謹慎觀察: 建議持續觀察股價走勢,留意是否有成交量伴隨的止跌訊號,例如出現連續的陽線(紅色 K 線),且 MA5 和 MA20 的交叉方向出現變化。
  • 分批布局: 若決定進場,建議採取分批布局的策略,將資金分攤在不同的價位,降低一次性投入的風險。可以等待股價回測前低的支撐區域(例如 58-60 元區間)時,小額試探性買進,並持續觀察後續走勢。
  • 關注基本面: 技術分析是重要的參考依據,但對於生技類股,基本面的消息(如藥物研發進度、臨床試驗結果、法規批准等)往往是影響股價的關鍵。建議投資人在決策前,應深入了解公司的基本面狀況,而非僅依賴技術線圖。

總結

綜合以上分析,台康生技 (6589) 在 2025 年 10 月 29 日的技術圖表顯示,股價短期內可能面臨盤整或小幅下跌的壓力,預計未來數天至數週的股價目標區間為 58 元至 64 元。 散戶投資人應以謹慎態度應對,建議暫時觀望,待市場出現更明確的止跌訊號後再考慮進場,並務必做好風險控管。

股權分散表

查看每日股權分散表表格
每週股權分散表分級資料
日期 100張以下持股比例 100~1000張持股比例 1000張以上持股比例 總股東人數
2024/09/20 34.04% 16.25% 49.63% 28,380
2024/09/27 34.15% 16.47% 49.3% 28,360
2024/10/04 34.01% 16.58% 49.34% 28,326
2024/10/11 34.01% 16.53% 49.4% 28,294
2024/10/18 34.17% 16.5% 49.25% 28,222
2024/10/25 33.93% 16.55% 49.45% 27,905
2024/11/01 33.56% 16.56% 49.81% 27,703
2024/11/08 33.12% 16.83% 49.96% 27,548
2024/11/15 33.23% 16.2% 50.49% 27,532
2024/11/22 33.24% 15.97% 50.71% 27,519
2024/11/29 33.14% 16.03% 50.77% 27,380
2024/12/06 32.85% 15.67% 51.42% 27,089
2024/12/13 33.68% 15.68% 50.57% 27,618
2024/12/20 33.75% 16.11% 50.05% 27,639
2024/12/27 33.87% 16.57% 49.49% 27,705
2025/01/03 33.93% 16.4% 49.61% 27,768
2025/01/10 33.62% 15.96% 50.33% 27,503
2025/01/17 33.39% 15.86% 50.68% 27,201
2025/01/22 33.17% 15.84% 50.92% 27,045
2025/02/07 33.02% 15.89% 51.01% 26,917
2025/02/14 33.01% 15.53% 51.38% 26,886
2025/02/21 32.92% 15.67% 51.32% 26,769
2025/02/27 32.96% 15.64% 51.34% 26,769
2025/03/07 32.93% 15.2% 51.79% 26,737
2025/03/14 32.91% 15.23% 51.78% 26,686
2025/03/21 32.85% 14.88% 52.21% 26,624
2025/03/28 32.67% 15.41% 51.85% 26,518
2025/04/02 32.58% 15.56% 51.79% 26,487
2025/04/11 32.49% 15.18% 52.26% 26,325
2025/04/18 32.48% 15.2% 52.25% 26,285
2025/04/25 32.39% 15.32% 52.2% 26,254
2025/05/02 32.5% 15.44% 51.97% 26,269
2025/05/09 32.55% 15.33% 52.05% 26,245
2025/05/16 32.6% 15.33% 52% 26,242
2025/05/23 32.64% 15.21% 52.09% 26,270
2025/05/29 32.59% 15.27% 52.07% 26,245
2025/06/06 32.5% 15.46% 51.98% 26,194
2025/06/13 32.5% 15.48% 51.94% 26,191
2025/06/20 32.61% 15.5% 51.81% 26,159
2025/06/27 32.6% 15.44% 51.88% 26,208
2025/07/04 32.74% 15.35% 51.84% 26,111
2025/07/11 32.67% 15.49% 51.77% 26,057
2025/07/18 32.54% 15.51% 51.86% 25,966
2025/07/25 32.35% 15.55% 52.02% 25,889
2025/08/01 32.28% 15.91% 51.72% 25,841
2025/08/08 32.37% 15.79% 51.76% 25,875
2025/08/15 32.32% 15.84% 51.78% 25,781
2025/08/22 32.37% 16.08% 51.47% 25,779
2025/08/29 32.52% 15.9% 51.52% 25,707
2025/09/05 32.38% 16.02% 51.52% 25,627
2025/09/12 32.24% 15.79% 51.88% 25,621
2025/09/19 32.42% 15.82% 51.68% 25,651
2025/09/26 32.63% 15.95% 51.34% 25,772
2025/10/03 32.15% 16.91% 50.87% 25,732
2025/10/09 32.06% 16.38% 51.47% 25,597
2025/10/17 32.09% 16.34% 51.49% 25,493
2025/10/23 32.14% 16.66% 51.14% 25,461

評論討論區

  • 目前尚無評論

發表評論